The Assessment of Nausea and Vomiting
- 1 May 1984
- Vol. 53 (S10), 2267-2278
- https://doi.org/10.1002/cncr.1984.53.s10.2267
Abstract
No abstract availableFunding Information
- National Cancer Institute (CA 11198, CA 26832)
- American Cancer Society (PDT 217)
This publication has 62 references indexed in Scilit:
- Emesis as a Critical Problem in ChemotherapyNew England Journal of Medicine, 1981
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981
- Δ9‐Tetrahydrocannabinol As An Antiemetic For Patients Receiving Cancer Chemotherapy. A Pilot StudyThe Journal of Clinical Pharmacology, 1981
- Nabilone: An Effective Antiemetic in Patients Receiving Cancer ChemotherapyThe Journal of Clinical Pharmacology, 1981
- Levonantradol for Chemotherapy‐Induced Emesis: Phase I—II Oral AdministrationThe Journal of Clinical Pharmacology, 1981
- Antiemetic Effect of Intramuscular Levonantradol in Patients Receiving Anticancer ChemotherapyThe Journal of Clinical Pharmacology, 1981
- Clinical Experience with Levonantradol Hydrochloride in the Prevention of Cancer Chemotherapy-Induced Nausea and VomitingThe Journal of Clinical Pharmacology, 1981
- Methylprednisolone as an AntiemeticNew England Journal of Medicine, 1981
- Trimethobenzamide HCI in the Treatment of Nausea and Vomiting Associated with Antineoplastic ChemotherapyThe Journal of Clinical Pharmacology, 1980
- Droperidol Prevents Nausea and Vomiting fromcis-PlatinumNew England Journal of Medicine, 1979